Prevention & Healthy Ageing: The role of adult vaccination as part of healthy ageing
How best can societies respond to the threat of pneumococcal diseases such as meningitis, bacteraemia and pneumonia in the context of rapidly ageing populations and demographic change?
This new report, published by Pfizer considers how removing barriers to adult vaccination could address this major public health issue.
After outlining the value of adult immunisation and the nature of the challenge posed by widespread pneumococcal infection, the report identifies a variety of barriers preventing individuals from protecting themselves against one of the most common vaccine-preventable diseases in adults.
The report notes that barriers to adult immunisation include: